Home Healthcare Pharmaceuticals Atrial Fibrillation Drugs Market

Atrial Fibrillation Drugs Market Size, Share & Trends Analysis Report By Type (Paroxysmal, Permanent, Persistent), By Route of Administration (Oral, Injectable), By End-User (Hospitals, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4946DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Atrial Fibrillation Drugs Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Paroxysmal
    2. Permanent
    3. Persistent
  2. Atrial Fibrillation Drugs Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Injectable
  3. Atrial Fibrillation Drugs Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Others
  4. Regional Atrial Fibrillation Drugs Market
    1. North America
      1. North America Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Paroxysmal
        2. Permanent
        3. Persistent
      2. North America Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      3. North America Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others
      4. U.S. Atrial Fibrillation Drugs Market
        1. U.S. Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. U.S. Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. U.S. Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      5. Canada Atrial Fibrillation Drugs Market
        1. Canada Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Canada Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Canada Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
    2. Europe
      1. Europe Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Paroxysmal
        2. Permanent
        3. Persistent
      2. Europe Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      3. Europe Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others
      4. U.K. Atrial Fibrillation Drugs Market
        1. U.K. Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. U.K. Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. U.K. Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      5. Germany Atrial Fibrillation Drugs Market
        1. Germany Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Germany Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Germany Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      6. France Atrial Fibrillation Drugs Market
        1. France Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. France Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. France Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      7. Spain Atrial Fibrillation Drugs Market
        1. Spain Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Spain Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Spain Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      8. Italy Atrial Fibrillation Drugs Market
        1. Italy Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Italy Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Italy Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      9. Russia Atrial Fibrillation Drugs Market
        1. Russia Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Russia Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Russia Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      10. Nordic Atrial Fibrillation Drugs Market
        1. Nordic Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Nordic Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Nordic Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      11. Benelux Atrial Fibrillation Drugs Market
        1. Benelux Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Benelux Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Benelux Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      12. Rest of Europe Atrial Fibrillation Drugs Market
        1. Rest of Europe Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Rest of Europe Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Rest of Europe Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
    3. APAC
      1. APAC Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Paroxysmal
        2. Permanent
        3. Persistent
      2. APAC Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      3. APAC Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others
      4. China Atrial Fibrillation Drugs Market
        1. China Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. China Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. China Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      5. Korea Atrial Fibrillation Drugs Market
        1. Korea Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Korea Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Korea Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      6. Japan Atrial Fibrillation Drugs Market
        1. Japan Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Japan Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Japan Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      7. India Atrial Fibrillation Drugs Market
        1. India Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. India Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. India Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      8. Australia Atrial Fibrillation Drugs Market
        1. Australia Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Australia Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Australia Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      9. Singapore Atrial Fibrillation Drugs Market
        1. Singapore Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Singapore Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Singapore Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      10. Taiwan Atrial Fibrillation Drugs Market
        1. Taiwan Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Taiwan Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Taiwan Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      11. South East Asia Atrial Fibrillation Drugs Market
        1. South East Asia Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. South East Asia Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. South East Asia Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      12. Rest of Asia-Pacific Atrial Fibrillation Drugs Market
        1. Rest of Asia-Pacific Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Rest of Asia-Pacific Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Rest of Asia-Pacific Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
    4. Middle East and Africa
      1. Middle East and Africa Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Paroxysmal
        2. Permanent
        3. Persistent
      2. Middle East and Africa Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      3. Middle East and Africa Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others
      4. UAE Atrial Fibrillation Drugs Market
        1. UAE Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. UAE Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. UAE Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      5. Turkey Atrial Fibrillation Drugs Market
        1. Turkey Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Turkey Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Turkey Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      6. Saudi Arabia Atrial Fibrillation Drugs Market
        1. Saudi Arabia Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Saudi Arabia Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Saudi Arabia Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      7. South Africa Atrial Fibrillation Drugs Market
        1. South Africa Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. South Africa Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. South Africa Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      8. Egypt Atrial Fibrillation Drugs Market
        1. Egypt Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Egypt Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Egypt Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      9. Nigeria Atrial Fibrillation Drugs Market
        1. Nigeria Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Nigeria Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Nigeria Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      10. Rest of MEA Atrial Fibrillation Drugs Market
        1. Rest of MEA Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Rest of MEA Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Rest of MEA Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
    5. LATAM
      1. LATAM Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
        1. Paroxysmal
        2. Permanent
        3. Persistent
      2. LATAM Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectable
      3. LATAM Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others
      4. Brazil Atrial Fibrillation Drugs Market
        1. Brazil Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Brazil Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Brazil Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      5. Mexico Atrial Fibrillation Drugs Market
        1. Mexico Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Mexico Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Mexico Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      6. Argentina Atrial Fibrillation Drugs Market
        1. Argentina Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Argentina Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Argentina Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      7. Chile Atrial Fibrillation Drugs Market
        1. Chile Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Chile Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Chile Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      8. Colombia Atrial Fibrillation Drugs Market
        1. Colombia Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Colombia Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Colombia Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
      9. Rest of LATAM Atrial Fibrillation Drugs Market
        1. Rest of LATAM Atrial Fibrillation Drugs Market By Type 2022-2034 (USD MILLION/ Units)
          1. Paroxysmal
          2. Permanent
          3. Persistent
        2. Rest of LATAM Atrial Fibrillation Drugs Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Injectable
        3. Rest of LATAM Atrial Fibrillation Drugs Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Ambulatory Surgical Centers
          3. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.